ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Other DCT Concepts Approved By BSC

June 6, 1986

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981